VAP & Care of Tracheostomy Tubes & Trach Patients

Ventilator-Associated Pneumonia/Care of Tracehostomy Tubes and Trach Patients-Ventilator-associated pneumonia (VAP) is defined as a lower respiratory tract infection occurring at least 2 days after beginning mechanical ventilation. The estimated associated mortality rate is 24% to 50%. Because VAP is prevalent in ICU patients on mechanical ventilation, numerous studies have been undertaken to determine ways to decrease its incidence. One area of study surrounds the utility of early tracheostomy as a deterrent to VAP. The association of tracheostomy with VAP, the benefits of an early tracesotomy is the purpose of Dr. Durbin’s review. Tracheostomy is an intensive-care measure that requires specialized care and monitoring.

Despite its potential for reducing ventilatorassociated pneumonia, it has its own risks,
which are minimized by careful attention to device and patient care. In this issue of
Perspectives, we have assembled a panel of experts to discuss trach care, strategies to
minimize morbidity and mortality in this patient population, patient and family education,
and decisions regarding weaning and decannulation. Differences in adult versus pediatric
populations are also highlighted.

This course covers trach care, strategies to minimize morbidity and mortality in this patient population, patient and family education, and decisions regarding weaning and decannulation. Differences in adult versus pediatric populations are also highlighted. Discuss the different impact that early versus late tracheostomy has on outcomes on medical compared to surgical/trauma patients. List 4 reasons that a study may not show improved outcomes with early versus later tracheostomy. List the elements of the “ventilator bundle” and suggest at least three other clinician actions that can influence the development of VAP.

1.0 Free CRCE for Respiratory Therapy